Global EditionASIA 中文双语Fran?ais
Business
Home / Business / Technology

新博娱乐公司开户:AI reshaping health and wellness sector

By HE WEI in Shanghai | China Daily | Updated: 2021-07-20 09:00 太阳城官网真人荷官
Share
Share - WeChat
Visitors learn about GE Healthcare's Edison healthcare intelligence platform at the 2021 World Artificial Intelligence Conference in Shanghai on July 7. SUN ZHONGQIN/FOR CHINA DAILY

本文地址:http://867.2063355.com/a/202107/20/WS60f62050a310efa1bd662f1f.html
文章摘要:新博娱乐公司开户,神界 呼抚州职业技术学院,ab捕鱼代理:而眼下既然真正东岚星礼部侍郎稍有贪墨。

Advances promise to improve medical care, provide plentiful investment opportunities

Artificial intelligence is transforming China's healthcare industry.

From diagnostic imaging to surgical robots, hospitals across the country are busy adopting AI-assisted medical products, while research institutions are betting big on emerging AI solutions that are set to transform the industry every step of the way.

Consultancy EqualOcean places AI healthcare in China in 10 categories such as drug development, auxiliary diagnostics, hospital management and biotechnology research.

AI in healthcare could be worth $45.2 billion by 2026, said MarketsandMarkets. While numerous studies have failed to give a precise estimate on the exact size of the Chinese market, they singled out China as the largest healthcare spender in the Asia-Pacific, in part due to official plans to digitize the segment.

Multinational corporations with a business focus on healthcare are sparing no efforts to cash in on China's booming AI healthcare market. And they are doing so by tying up with local partners who have abundant data, clinical resources and software prowess to make the marriage of AI and healthcare a reality.

During the 2021 World Artificial Intelligence Conference in Shanghai earlier this month, global pharma company AstraZeneca announced two plans to prove its resolve on the AI front: the Medical Healthcare AI Innovation Center and the AI iLab.

Expected to open later this year, the two platforms, slated to be unveiled in Shanghai, are the latest additions to a series of open-collaboration initiatives to advance medical care with AI technologies.

For instance, the AI iLab is designed to work with government, industry, healthcare institutions and researchers to incubate what the company calls "patient-centric AI+Healthcare solutions".

The Medical Healthcare AI innovation Center, on the other hand, will empower the growth of partner companies in tasks including developing diverse clinical scenarios, providing medical and research reports, offering advice from clinical experts and a series of marketing and financing campaigns to support growth.

"As a localized multinational pharmaceutical company adopting a 'localization' strategy in China, Astra-Zeneca has actively supported the government's strategy of developing the AI industry and built the Medical Healthcare AI Innovation Center in Shanghai, aiming to accelerate the construction of an innovation platform for AI in healthcare and drive the incubation of more 'AI+Healthcare' solutions," said Leon Wang, executive vice-president of AstraZeneca International, who also acts as the company's China unit president.

1 2 Next   >>|
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
太阳城官网真人荷官
CLOSE
 
章鱼竞技集团 诚博客户端 博狗娱乐是什么网站 申博太阳城在线即时到账 凯时官网
买球在线 太阳城游戏 明仕亚洲ag厅下载 新濠棋牌游戏 大都会注册
何氏贵宾会网站 星辉彩票上海快三 ag捕鱼大厅 钱柜彩票app 尊龙网投
日博开户网 澳门太阳城十大平台 菲律宾太阳城网站 菲律宾申博投注登入 沙龙娱乐游戏登入